Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies
BACKGROUND. Invasive aspergillosis (IA) has a poor prognosis in immunocompromised patients. Combinations of drugs that act on different targets are expected to improve the clinical efficacy of separate compounds. METHODS. Patients with proven or probable IA were randomized in a prospective, open pil...
Gespeichert in:
Veröffentlicht in: | Cancer 2007-12, Vol.110 (12), p.2740-2746 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!